Skip to main content

Zymeworks Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

ZYME$30.81+4.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(In thousands except share data)

June 30,2026December 31,2025
Assets · (unaudited)
Current assets:
Cash and cash equivalents$179,413$41,157
Short-term marketable securities91,286187,640
Accounts receivable5,9304,638
Prepaid expenses and other current assets21,75915,332
Total current assets298,388248,767
Long-term marketable securities51,77741,787
Long-term prepaids and other assets2,2816,674
Deferred tax asset4,3544,707
Property and equipment, net13,95515,502
Operating lease right-of-use assets13,19515,724
Intangible assets, net9981,350
Goodwill12,01612,016
Total assets$396,964$346,527
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued liabilities$27,458$36,346
Income tax payable4583
Current portion of operating lease liability3,3043,471
Deferred revenue16,4362,418
Total current liabilities47,24342,318
Long-term portion of operating lease liability12,70314,796
Deferred revenue—14,606
Liability related to sale of future royalties252,631—
Other long-term liabilities278278
Deferred tax liability3,7406,028
Total liabilities316,59578,026
Stockholders’ equity:
Common stock, $0.00001 par value; 900,000,000 authorized shares at June 30, 2026 and December 31, 2025, respectively; 71,412,072 and 74,638,413 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively1,133,9591,105,176
Preferred shares, $0.00001 par value; 100,000,000 authorized shares of preferred stock, out of which, one share of preferred stock is a share of Special Voting Preferred Stock and outstanding as of June 30, 2026 and December 31, 2025——
Exchangeable shares, no par value, 550,000 and 553,184 issued and outstanding shares at June 30, 2026 and December 31, 2025, respectively7,8927,938
Additional paid-in capital116,450114,626
Accumulated other comprehensive loss(6,694)(6,079)
Accumulated deficit(1,171,238)(953,160)
Total stockholders’ equity80,369268,501
Total liabilities and stockholders’ equity$396,964$346,527
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.